Finnish Industry Investment and Karolinska Development III AB, an affiliated company of Karolinska Holding AB, have invested EUR 1.5m in BioCis Pharma, a therapy company. The investment round will be used to fuel the speed of product development and begin initial clinical studies.
Consortium of investors supporting the funding round includes existing and new backers
Vehicle is larger than its predecessor, Xenon Private Equity VI, a €184m fund closed in July 2014
GP intends to boost the company's organic growth and further strengthen its market position
Acquisition of the family-owned company adds to the GP's industrial portfolio